PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
Clinical trial NCT01973660 · COMPLETED
Trial details
- NCT number
- NCT01973660
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2016-06-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.